News Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
7.48 ^CNY	-1.58%		-1.58%	-20.09%

Apr. 02	Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	CI
Mar. 27	China Energy Engineering Issues Apology Over Former Director's Stake Disposal Breaches	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	Apr. 01	CI
China Energy Engineering Issues Apology Over Former Director's Stake Disposal Breaches	Mar. 27	MT
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.	Jan. 02	CI
Zhejiang Hisun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Dec. 22	CI
Zhejiang Hisun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	Dec. 21	CI
Gogox Holdings Chairman Steps Down	Dec. 18	MT
Hisun Pharmaceutical's Unit Gets Certification for Imported Drug from Pfizer	Dec. 15	MT
Hisun Pharmaceutical CFO Resigns	Nov. 30	MT
Hisun Pharmaceutical's Unit Gets Import Drug Certificate for Methylprednisolone Tablets	Nov. 29	MT
Hisun Pharmaceutical's Unit Gets Nod for Carprofen Tablets for Dogs	Nov. 29	MT
Hisun Pharma Registers New Veterinary Drug	Nov. 09	MT
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Hisun Pharmaceutical Gets China Nod to Market Cytarabine	23-10-11	MT
Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 22, 2022.	23-09-20	CI
Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 22, 2022, has closed with 18,489,100 shares, representing 1.55% for CNY 194.73 million.	23-09-19	CI
Zhejiang Hisun Pharmaceutical Co., Ltd.(XSSC:600267) added to S&P Global BMI Index	23-09-18	CI
Zhejiang Hisun Pharmaceutical Co., Ltd.(XSSC:600267) added to FTSE All-World Index	23-09-18	CI
Shanghai Shyndec Pharma Gets Nod to Market Blood Sugar Drug Ingredient	23-09-14	MT
Hisun Pharma Unit Gets Nod to Produce Apremilast API	23-09-05	MT
Hisun Pharma Chairman, Vice Chairman Resign	23-09-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Summary

Filters